Treatment of metastatic disease.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000556:secondary / Q000628:therapy; D003110:Colonic Neoplasms / Q000556:secondary; D004938:Esophageal Neoplasms / Q000556:secondary; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008545:Melanoma / Q000556:secondary; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000556:secondary; D012509:Sarcoma / Q000556:secondary; D012983:Soft Tissue Neoplasms / Q000556:secondary; D013274:Stomach Neoplasms / Q000556:secondary
D000970:Antineoplastic Agents